Dario Siniscalco
Dario Siniscalco
Universitą della Campania
Verified email at
Cited by
Cited by
Inflammation and neuro-immune dysregulations in autism spectrum disorders
D Siniscalco, S Schultz, AL Brigida, N Antonucci
Pharmaceuticals 11 (2), 56, 2018
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption
F Rossi, D Siniscalco, L Luongo, L De Petrocellis, G Bellini, S Petrosino, ...
Bone 44 (3), 476-484, 2009
Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders
MR Iovene, F Bombace, R Maresca, A Sapone, P Iardino, A Picardi, ...
Mycopathologia 182, 349-363, 2017
Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain
D Siniscalco, C Fuccio, C Giordano, F Ferraraccio, E Palazzo, L Luongo, ...
Pharmacological research 55 (2), 158-166, 2007
Role of neurotrophins in neuropathic pain
D Siniscalco, C Giordano, F Rossi, S Maione, V de Novellis
Current neuropharmacology 9 (4), 523-529, 2011
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice
D Siniscalco, C Giordano, U Galderisi, L Luongo, N Alessio, ...
Cellular and Molecular Life Sciences 67, 655-669, 2010
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice
D Siniscalco, C Giordano, U Galderisi, L Luongo, V de Novellis, F Rossi, ...
Frontiers in integrative neuroscience 5, 79, 2011
Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
D Siniscalco, A Sapone, C Giordano, A Cirillo, L de Magistris, F Rossi, ...
Journal of autism and developmental disorders 43, 2686-2695, 2013
AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
B Costa, D Siniscalco, AE Trovato, F Comelli, ML Sotgiu, M Colleoni, ...
British journal of pharmacology 148 (7), 1022-1032, 2006
A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice
C Fuccio, C Luongo, P Capodanno, C Giordano, MA Scafuro, ...
European journal of pharmacology 603 (1-3), 42-49, 2009
TRPV1-dependent and-independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception
C Giordano, L Cristino, L Luongo, D Siniscalco, S Petrosino, F Piscitelli, ...
Cerebral cortex 22 (11), 2495-2518, 2012
Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II
V de Novellis, D Siniscalco, U Galderisi, C Fuccio, M Nolano, L Santoro, ...
Neuropharmacology 46 (4), 468-479, 2004
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels
F Rossi, S Perrotta, G Bellini, L Luongo, C Tortora, D Siniscalco, ...
Haematologica 99 (12), 1876, 2014
Antibodies against food antigens in patients with autistic spectrum disorders
L de Magistris, A Picardi, D Siniscalco, MP Riccio, A Sapone, R Cariello, ...
BioMed research international 2013, 2013
The A1 adenosine receptor as a new player in microglia physiology
L Luongo, F Guida, R Imperatore, F Napolitano, L Gatta, L Cristino, ...
Glia 62 (1), 122-132, 2014
Epigenetic findings in autism: new perspectives for therapy
D Siniscalco, A Cirillo, JJ Bradstreet, N Antonucci
International Journal of Environmental Research and Public Health 10 (9 …, 2013
Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain
F Guida, S Boccella, C Belardo, M Iannotta, F Piscitelli, F De Filippis, ...
Brain, Behavior, and Immunity 85, 128-141, 2020
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease
B D'Agostino, N Sullo, D Siniscalco, A De Angelis, F Rossi
Expert opinion on biological therapy 10 (5), 681-687, 2010
Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?
D Siniscalco, A Sapone, A Cirillo, C Giordano, S Maione, N Antonucci
BioMed Research International 2012, 2012
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of …
V de Novellis, D Vita, L Gatta, L Luongo, G Bellini, M De Chiaro, ...
Molecular pain 7, 1744-8069-7-7, 2011
The system can't perform the operation now. Try again later.
Articles 1–20